
Contract to develop avian flu vaccine canceled by HHS
Moderna’s $776 million in funding to develop an avian flu vaccine for people was canceled May 28 following concerns from the U.S. Department of Health and Human Services (HHS) about the safety of mRNA technology. “After a rigorous review, we concluded that …